FindTrial
Sign In

Evaluation of pain reduction with Salicin Gel in Patients with Jaw Muscle Pain

Formulation and Assessment of therapeutic effectiveness of Salicin as a Emulgel for treatment of Myogenous Temporomandibular disorders - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/111866
Enrollment
24
Registered
2026-06-03
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

Intervention1: Salicin gel: The formulated topical gel is instructed to be applied extra orally over the skin on the affected area thrice daily for 30 days Control Intervention1: Diclofenac gel: The d

Sponsors

Saveetha Dental College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Myogenous Disorders

Exclusion criteria

Exclusion criteria: Developemntal diosrders Degenerative disorders Disc displacement Mobility disorders of TMJ Patients who underwent previous treatment for TMDs Patients who are allergic to Salicin

Design outcomes

Primary

MeasureTime frame
Formulation of Salicin Gel.Timepoint: Baseline , 15th day , 30th day—

Secondary

MeasureTime frame
Pain Reduction. Mouth opening. Side EffectsTimepoint: Baseline , 15th day , 30th day—

Countries

India

Contacts

Public ContactJayanth Kumar Vadivel

Saveetha Dental College and Hospitals

jayanthkumar@saveetha.com8056135807

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026